Skin penetration enhancers

Albery, 1979, Percutaneous absorption: in vivo experiments, J. Pharm. Pharmacol., 31, 140, 10.1111/j.2042-7158.1979.tb13456.x

Allenby, 1969, The effect of heat, pH and organic solvents on the electrical impedance and permeability of excised human skin, Br. J. Dermatol., 81, 31, 10.1111/j.1365-2133.1969.tb16059.x

Andega, 2001, Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin, J. Control. Release, 77, 17, 10.1016/S0168-3659(01)00439-4

Anigbogu, 1995, Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum, Int. J. Pharm., 125, 265, 10.1016/0378-5173(95)00141-5

Artusi, 2004, Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro, J. Pharm. Sci., 93, 2431, 10.1002/jps.20152

Ashton, 1986, Some effects of a non-ionic surfactant on topical availability, J. Pharm. Pharmacol., 38, 70, 10.1111/j.2042-7158.1986.tb14299.x

Aungst, 1990, Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines, Pharm. Res., 7, 712, 10.1023/A:1015859320604

Barrett, 1965, The effect of particle size on the percutaneous absorption of fluocinolone acetonide, Br. J. Dermatol., 77, 576, 10.1111/j.1365-2133.1965.tb14578.x

Basketter, 2004, Strong irritants masquerading as skin allergens: the case of benzalkonium chloride, Contact Dermatitis, 50, 213, 10.1111/j.0105-1873.2004.00331.x

Berner, 1989, Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402, 10.1002/jps.2600780512

Berner, 1989, Ethanol and water sorption into stratum corneum and model systems, J. Pharm. Sci., 78, 472, 10.1002/jps.2600780611

Boddé, 1989, Visualisation of normal and enhanced HgCl2 transport through human skin in vitro, Int. J. Pharm., 53, 13, 10.1016/0378-5173(89)90356-6

Bommannan, 1991, Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy, J. Control. Release, 16, 299, 10.1016/0168-3659(91)90006-Y

Bonnist, 2011, Measuring the penetration of a skin sensitizer and its delivery vehicles simultaneously with confocal Raman spectroscopy, Skin Pharmacol. Physiol., 24, 274, 10.1159/000328729

Bouwstra, 1989, Effect of N-alkyl-azocycloheptan-2-ones including azone on the thermal behaviour of human stratum corneum, Int. J. Pharm., 52, 47, 10.1016/0378-5173(89)90087-2

Bouwstra, 1991, Thermodynamic and structural aspects of the skin barrier, J. Control. Release, 15, 209, 10.1016/0168-3659(91)90112-Q

Brinkmann, 2003, Role of isopropyl myristate, isopropyl alcohol and a combination of both in hydrocortisone permeation across the human stratum corneum, Skin Pharmacol. Appl. Skin Physiol., 16, 393, 10.1159/000072935

Brinkmann, 2005, An attempt to clarify the influence of glycerol, propylene glycol, isopropyl myristate and a combination of propylene glycol and isopropyl myristate on human stratum corneum, Pharmazie, 60, 215

Casal, 1984, Polymorphic phase behaviour of phospholipid membranes studies by infrared spectroscopy, Biochim. Biophys. Acta, 779, 381, 10.1016/0304-4157(84)90017-0

Coldman, 1969, Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles, J. Pharm. Sci., 58, 1098, 10.1002/jps.2600580912

Coldman, 1971, The in vitro penetration of fluocinonide through human skin from different volumes of DMSO, Br. J. Dermatol., 85, 457, 10.1111/j.1365-2133.1971.tb14053.x

Cornwell, 1994, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol., 46, 261, 10.1111/j.2042-7158.1994.tb03791.x

Crank, 1975, The diffusion equations, 1

Degim, 1999, The effects of Azone and capsaicin on the permeation of naproxen through human skin, Int. J. Pharm., 179, 21, 10.1016/S0378-5173(98)00353-6

Denda, 2001, Epidermal proliferative response induced by sodium dodecyl sulphate varies with environmental humidity, Br. J. Dermatol., 145, 252, 10.1046/j.1365-2133.2001.04342.x

Dias, 2008, In vivo infrared spectroscopy studies of alkanol effects on human skin, Eur. J. Pharm. Biopharm., 69, 1171, 10.1016/j.ejpb.2008.02.006

Dominguez, 1977, A new approach to the theory of adsorption and permeability of surfactants on keratinic proteins: the specific behaviour of certain Hydrophobie chains, J. Soc. Cosmet. Chem., 28, 165

Edwards, 1995, Analysis of enhanced transdermal transport by skin electroporation, J. Control. Release, 34, 211, 10.1016/0168-3659(94)00132-E

Engblom, 1998, Phase coexistence in cholesterol-fatty acid mixtures and the effect of the penetration enhancer Azone, J. Control. Release, 52:, 271, 10.1016/S0168-3659(97)00219-8

Franz, 1983, On the bioavailability of topical formulations of clindamycin hydrochloride, J. Am. Acad. Dermatol., 9, 66, 10.1016/S0190-9622(83)70108-8

Friend, 1991, Transdermal delivery of levonorgestrel, Med. Res. Rev., 11, 49, 10.1002/med.2610110105

Friend, 1991, Cutaneous effects of transdermal levonorgestrel, Food Chem. Toxicol., 29, 639, 10.1016/0278-6915(91)90147-Y

Funk, 1995, Sunscreen intolerance. Contact sensitization, photocontact sensitization, and irritancy of sunscreen agents, Dermatol. Clin., 13, 473, 10.1016/S0733-8635(18)30094-9

Ghosh, 2007, The role of sodium dodecyl sulfate (SDS) micelles in inducing skin barrier perturbation in the presence of glycerol, J. Cosmet. Sci., 58, 109

Goates, 1994, Enhanced permeation of polar compounds through human epidermis I. Permeability and membrane structural changes in the presence of short chain alcohols, Biochim. Biophys. Acta, 1195, 169, 10.1016/0005-2736(94)90024-8

Godavarthy, 2009, Design of improved permeation enhancers for transdermal drug delivery, J. Pharm. Sci., 98, 4085, 10.1002/jps.21940

Golden, 1987, Role of stratum corneum lipid fluidity in transdermal drug flux, J. Pharm. Sci., 76, 25, 10.1002/jps.2600760108

Harrison, 1996, The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum, Pharm. Res., 13, 542, 10.1023/A:1016037803128

Higuchi, 1960, Physical chemical analysis of percutaneous absorption process from creams and ointments, J. Soc. Cosmet. Chem., 11, 85

Hirvonen, 1995, Mechanism and reversibility of penetration enhancer action in the skin, Eur. J. Pharm. Biopharm., 40, 81

Hoelgaard, 1985, Dermal drug delivery – improvement by choice of vehicle or drug derivative, J. Control. Release, 2, 111, 10.1016/0168-3659(85)90037-9

Hoogstraate, 1991, Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones, Int. J. Pharm., 76, 37, 10.1016/0378-5173(91)90341-K

Jungbauer, 2001, Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone, Contact Dermatitis, 45, 303, 10.1034/j.1600-0536.2001.450514.x

Kasting, 1993, Skin penetration enhancement of triprolidine base by propylene glycol, J. Pharm. Sci., 82, 551, 10.1002/jps.2600820525

Klamerus, 1992, Effects of some hydrophilic permeation enhancers on the absorption of bepridil through excised human skin, Drug Dev. Ind. Pharm., 18, 1411, 10.3109/03639049209040848

Kurihara-Bergstrom, 1990, Percutaneous absorption enhancement of an ionic molecule by ethanol–water systems in human skin, Pharm. Res., 7, 762, 10.1023/A:1015879925147

Kushla, 1991, Correlation of water and lidocaine flux enhancement by cationic surfactants in vitro, J. Pharm. Sci., 80, 1079, 10.1002/jps.2600801117

Lademann, 2011, Penetration and storage of particles in human skin: perspectives and safety aspects, Eur. J. Pharm. Biopharm., 77, 465, 10.1016/j.ejpb.2010.10.015

Lane, 2012, Passive skin permeation enhancement, 23

Lane, 2012, Rational formulation design, Int. J. Cosmet. Sci., 34, 496, 10.1111/j.1468-2494.2012.00747.x

Lane, 2013, The transdermal delivery of fentanyl, Eur. J. Pharm. Biopharm., 10.1016/j.ejpb.2013.01.018

Leopold, 1995, An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC), J. Pharm. Pharmacol., 47, 276, 10.1111/j.2042-7158.1995.tb05795.x

Lin, 1996, Ocular and dermal irritation studies of some quaternary ammonium compounds, Food Chem. Toxicol., 34, 177, 10.1016/0278-6915(95)00099-2

Liu, 1991, Cotransport of estradiol and ethanol through human skin in vitro: understanding the permeant/enhancer flux relationship, Pharm. Res., 8, 938, 10.1023/A:1015876117627

Liu, 2009, Effects of isopropanol-isopropyl myristate binary enhancers on in vitro transport of estradiol in human epidermis: a mechanistic evaluation, J. Pharm. Sci., 98, 565, 10.1002/jps.21459

Maibach, 1967, The effect of DMSO on percutaneous penetration of hydrocortisone and testosterone in man, Ann. N. Y. Acad. Sci., 141, 423, 10.1111/j.1749-6632.1967.tb34906.x

Menczel, 1985, Skin binding during percutaneous penetration, 43

Menon, 2012, The structure and function of the stratum corneum, Int. J. Pharm., 435, 3, 10.1016/j.ijpharm.2012.06.005

Michaels, 1975, Drug permeation through human skin: theory and in vitro experimental measurement, AIChE J., 21, 985, 10.1002/aic.690210522

Morgan, 1998, Enhanced skin permeation of sex hormones with novel topical spray vehicles, J. Pharm. Sci., 87, 1213, 10.1021/js980025k

Naik, 1995, Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans, J. Control. Release, 37, 299, 10.1016/0168-3659(95)00088-7

Nater, 1977, Histological aspects of skin reactions to propylene glycol, Contact Dermatitis, 3, 181, 10.1111/j.1600-0536.1977.tb03643.x

Nicolazzo, 2005, Synergistic enhancement of testosterone transdermal delivery, J. Control. Release, 103, 577, 10.1016/j.jconrel.2004.12.007

Notman, 2008, Simulations of skin barrier function: free energies of hydrophobic and hydrophilic transmembrane pores in ceramide bilayers, Biophys. J., 95, 4763, 10.1529/biophysj.108.138545

Ongpipattanakul, 1991, Evidence that oleic acid exists in a separate phase within stratum corneum lipids, Pharm. Res., 8, 350, 10.1023/A:1015845632280

Ostrenga, 1971, Significance of vehicle composition II. Prediction of optimal vehicle composition, J. Pharm. Sci., 60, 1180, 10.1002/jps.2600600813

Pannatier, 1978, The skin as a drug-metabolizing organ, Drug Metab. Rev., 8, 319, 10.3109/03602537808993791

Pershing, 1990, Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo, Pharm. Res., 7, 170, 10.1023/A:1015832903398

Potts, 1993, 269

Pudney, 2007, An in vivo confocal Raman study of the delivery of trans retinol to the skin, Appl. Spectrosc., 61, 804, 10.1366/000370207781540042

Rachakonda, 2008, Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin, Pharm. Res., 2697, 10.1007/s11095-008-9696-y

Rammler, 1967, Biological implications of DMSO based on a review of its chemical properties, Ann. N. Y. Acad. Sci., 141, 13, 10.1111/j.1749-6632.1967.tb34861.x

Remane, 2006, Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects, J. Pharmacokinet. Pharmacodyn., 33, 719, 10.1007/s10928-006-9019-z

Robbins, 1983, Some observations on the swelling of human epidermal membrane, J. Soc. Cosmet. Chem., 34, 21

Roth, 2011, Diclofenac sodium topical solution 1.5% w/w with dimethyl sulfoxide compared with placebo for the treatment of osteoarthritis: pooled safety results, Postgrad. Med., 123, 180, 10.3810/pgm.2011.11.2507

Ryan, 1975, In vivo method for monitoring polysorbate 85 effect on epidermal permeability, J. Pharm. Sci., 64, 671, 10.1002/jps.2600640421

Santos, 2012, Influence of penetration enhancer on drug permeation from volatile formulations, Int. J. Pharm., 439, 260, 10.1016/j.ijpharm.2012.09.031

Santos, 2011, Formulation issues associated with transdermal fentanyl delivery, Int. J. Pharm., 416, 155

Santos, 2010, Oxybutynin permeation in skin: the influence of drug and solvent activity, Int. J. Pharm., 384, 67, 10.1016/j.ijpharm.2009.09.043

Scheuplein, 1967, Mechanism of percutaneous absorption II. Transient diffusion and the relative importance of various routes of skin penetration, J. Invest. Dermatol., 48, 79, 10.1038/jid.1967.11

Southwell, 1983, Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine, J. Invest. Dermatol., 80, 507, 10.1111/1523-1747.ep12535090

Stoughton, 1965, Dimethylsulfoxide (DMSO) induction of a steroid reservoir in human skin, Arch. Dermatol., 91, 657, 10.1001/archderm.1965.01600120089022

Stoughton, 1983, Azone: a new non-toxic enhancer of cutaneous penetration, Drug Dev. Ind. Pharm., 9, 725, 10.3109/03639048309044701

Törmä, 2008, Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo, J. Invest. Dermatol., 128, 1212, 10.1038/sj.jid.5701170

Traversa, 2005

Tregear, 1966, Molecular movement. The permeability of skin

Trottet, 2004, Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride, Int. J. Pharm., 274, 213, 10.1016/j.ijpharm.2004.01.013

van der Valk, 1985, Eczematous (irritant and allergic) reactions of the skin and barrier function as determined by water vapour loss, Clin. Exp. Dermatol., 10, 185, 10.1111/j.1365-2230.1985.tb00557.x

Vickers, 1963, Existence of reservoir in the stratum corneum: experimental proof, Arch. Dermatol., 88, 20, 10.1001/archderm.1963.01590190026002

Watkinson, 2009, Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin, Skin Pharmacol. Physiol., 22, 15, 10.1159/000183922

Watkinson, 2009, Optimisation of cosolvent concentration for topical drug delivery – II: influence of propylene glycol on ibuprofen permeation, Skin Pharmacol. Physiol., 22, 225, 10.1159/000231528

Wiechers, 1987, Percutaneous absorption and elimination of the penetration enhancer Azone inhumans, Pharm. Res., 4, 519, 10.1023/A:1016439908270

Williams, 1991, Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17, 10.1023/A:1015813803205

Yamane, 1995, Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action, J. Pharm. Pharmacol., 47, 978, 10.1111/j.2042-7158.1995.tb03282.x